Medication info
Esoduo Tablet 20/800 mg

Esoduo Tablet 20/800 mg

Prescription medicationTabletOral
Ingredient · strength
Esomeprazole Magnesium Trihydrate Pellet›22.26mg / 1 tabletSodium Bicarbonate›800mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Light pink oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201801860 · Approved 2018.04.30 · Insurance code 643308040

Summary

Main use
Treatment and prevention of recurrence of gastroesophageal reflux disease (including reflux esophagitis)
Who takes it
Adults
Adult dose
Take this medicine on an empty stomach at least 1 hour before a meal. When taking this medicine, swallow it whole with at least half a glass of water. Do not take it with any beverage other than water. Do not chew or crush this medicine. This medicine 20/800mg and 40/800mg contains 20 and 40mg of esomeprazole, respectively; however, note that two tablets of this medicine 20/800mg and one tablet of 40/800mg do not contain the same amount of sodium bicarbonate. 1. Adults Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40/800mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, administer for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20/800mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis · 20/800mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. · Once symptoms have resolved, subsequent episodes may be controlled with 20/800mg once daily. · In adults, 20/800mg may be administered as needed once daily. As-needed administration is not recommended for controlling recurrent symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20/800 mg.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment and prevention of recurrence of gastroesophageal reflux disease (including reflux esophagitis)

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • symptoms of gastroesophageal reflux disease
View approved original text

This medication is used for patients with gastroesophageal reflux disease (GERD). It is particularly effective in treating erosive esophagitis and is also utilized as a long-term maintenance therapy to prevent recurrence in esophagitis patients. Additionally, it helps alleviate symptoms of gastroesophageal reflux disease that do not accompany esophagitis. This medication is used to improve uncomfortable symptoms in your stomach and esophagus.

How to take

Adult dose

Take this medicine on an empty stomach at least 1 hour before a meal. When taking this medicine, swallow it whole with at least half a glass of water. Do not take it with any beverage other than water. Do not chew or crush this medicine. This medicine 20/800mg and 40/800mg contains 20 and 40mg of esomeprazole, respectively; however, note that two tablets of this medicine 20/800mg and one tablet of 40/800mg do not contain the same amount of sodium bicarbonate. 1. Adults Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40/800mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, administer for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20/800mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis · 20/800mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. · Once symptoms have resolved, subsequent episodes may be controlled with 20/800mg once daily. · In adults, 20/800mg may be administered as needed once daily. As-needed administration is not recommended for controlling recurrent symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20/800 mg.

Precautions

This medication should not be used in certain patients. Patients who have had an allergic reaction or hypersensitivity to this drug or its components should not take it. Additionally, patients taking certain antiviral medications such as Atazanavir, Nelfinavir, or Rilpivirine, as well as nursing mothers, should not use this drug. Caution is also required for patients with a history of myocardial infarction or heart-related diseases. Patients with poor liver or kidney function, elderly patients, patients with severe gastrointestinal ulcers, those with cardiopulmonary dysfunction, and patients with electrolyte imbalances should use this drug with caution. In particular, patients with electrolyte abnormalities such as hypokalemia, hypocalcemia, and hypochloremic alkalosis should take care due to the sodium bicarbonate included in this medication. Moreover, patients who need to limit sodium intake should be cautious when taking this medication. Various side effects may occur when taking this medication. For example, headache, dizziness, indigestion, abdominal pain, diarrhea, constipation, nausea, vomiting, skin rash, itching, and rarely severe allergic reactions or blood abnormalities may occur. Liver dysfunction, nephritis, myalgia, gynecomastia, and weakness have also been reported. This medication may increase the risk of gastrointestinal infections as it reduces stomach acid, which promotes bacterial growth in the stomach. Long-term use (especially for more than one year) may increase fracture risk, so patients at risk for osteoporosis should undergo regular examinations. Additionally, since this drug contains sugar, certain rare genetic disease patients should not take it. Long-term use of this medication may lower blood magnesium levels, so it's important to periodically monitor magnesium levels. Caution is warranted as magnesium deficiency can lead to muscle cramps, arrhythmias, and seizures. This drug can interact with other medications, so consult your physician when taking it with digoxin, warfarin, methotrexate, clopidogrel, tacrolimus, or certain antiviral agents. Close monitoring is necessary as blood levels of interacting medications may change. Data on the safety of this drug during pregnancy is limited; therefore, it should be administered cautiously to pregnant women, and it is advisable for nursing women to refrain from taking it. In case of overdose, there is no specific antidote, so appropriate treatment based on symptoms should be provided, along with standard supportive therapy. This drug should be kept out of the reach of children, and care should be taken to avoid transferring it to other containers, as this may degrade quality and pose risks.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, mental confusion, depression, aggression, hallucinations, headache, dizziness, altered sensation, drowsiness, taste disorders, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell's syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid nodules, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, muscle rigidity, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, visual disturbances, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, angioedema, increased sweating, otitis media, dysosmia, taste loss, parageusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyps, hypocalcemia, hypokalemia, rhabdomyolysis, alkalosis, edema, gastric distension, belching, rebound secretion of gastric acid, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light pink oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.